BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 17142749)

  • 1. Defective chemokine-directed lymphocyte migration and development in the absence of Rho guanosine diphosphate-dissociation inhibitors alpha and beta.
    Ishizaki H; Togawa A; Tanaka-Okamoto M; Hori K; Nishimura M; Hamaguchi A; Imai T; Takai Y; Miyoshi J
    J Immunol; 2006 Dec; 177(12):8512-21. PubMed ID: 17142749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune responses in mice deficient in Ly-GDI, a lymphoid-specific regulator of Rho GTPases.
    Yin L; Schwartzberg P; Scharton-Kersten TM; Staudt L; Lenardo M
    Mol Immunol; 1997 Apr; 34(6):481-91. PubMed ID: 9307064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutated D4-guanine diphosphate-dissociation inhibitor is found in human leukemic cells and promotes leukemic cell invasion.
    Nakata Y; Kondoh K; Fukushima S; Hashiguchi A; Du W; Hayashi M; Fujimoto J; Hata J; Yamada T
    Exp Hematol; 2008 Jan; 36(1):37-50. PubMed ID: 18037226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ly-GDI, a GDP-dissociation inhibitor of the RhoA GTP-binding protein, is expressed preferentially in lymphocytes.
    Scherle P; Behrens T; Staudt LM
    Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7568-72. PubMed ID: 8356058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vav, a GDP/GTP nucleotide exchange factor, interacts with GDIs, proteins that inhibit GDP/GTP dissociation.
    Groysman M; Russek CS; Katzav S
    FEBS Lett; 2000 Feb; 467(1):75-80. PubMed ID: 10664460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered cellular immunity in transgenic mice with T cell-specific expression of human D4-guanine diphosphate-dissociation inhibitor (D4-GDI).
    Kondoh K; Nakata Y; Yamaoka T; Itakura M; Hayashi M; Yamada K; Hata J; Yamada T
    Int Immunol; 2008 Oct; 20(10):1299-311. PubMed ID: 18689726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential properties of D4/LyGDI versus RhoGDI: phosphorylation and rho GTPase selectivity.
    Gorvel JP; Chang TC; Boretto J; Azuma T; Chavrier P
    FEBS Lett; 1998 Jan; 422(2):269-73. PubMed ID: 9490022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GDIs: central regulatory molecules in Rho GTPase activation.
    DerMardirossian C; Bokoch GM
    Trends Cell Biol; 2005 Jul; 15(7):356-63. PubMed ID: 15921909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted disruption of guanosine diphosphate-dissociation inhibitor for Rho-related proteins, GDID4: normal hematopoietic differentiation but subtle defect in superoxide production by macrophages derived from in vitro embryonal stem cell differentiation.
    Guillemot JC; Kruskal BA; Adra CN; Zhu S; Ko JL; Burch P; Nocka K; Seetoo K; Simons E; Lim B
    Blood; 1996 Oct; 88(7):2722-31. PubMed ID: 8839868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disruption of RhoGDI and RhoA regulation by a Rac1 specificity switch mutant.
    Wong KW; Mohammadi S; Isberg RR
    J Biol Chem; 2006 Dec; 281(52):40379-88. PubMed ID: 17074770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vav1 and Ly-GDI two regulators of Rho GTPases, function cooperatively as signal transducers in T cell antigen receptor-induced pathways.
    Groysman M; Hornstein I; Alcover A; Katzav S
    J Biol Chem; 2002 Dec; 277(51):50121-30. PubMed ID: 12386169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rho guanine dissociation inhibitors: pivotal molecules in cellular signalling.
    Olofsson B
    Cell Signal; 1999 Aug; 11(8):545-54. PubMed ID: 10433515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GM3 suppresses anchorage-independent growth via Rho GDP dissociation inhibitor beta in melanoma B16 cells.
    Wang P; Xu S; Wang Y; Wu P; Zhang J; Sato T; Yamagata S; Yamagata T
    Cancer Sci; 2011 Aug; 102(8):1476-85. PubMed ID: 21518140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of lovastatin on Rho isoform expression, activity, and association with guanine nucleotide dissociation inhibitors.
    Turner SJ; Zhuang S; Zhang T; Boss GR; Pilz RB
    Biochem Pharmacol; 2008 Jan; 75(2):405-13. PubMed ID: 17920041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rho GDP dissociation inhibitor-mediated disruption of Rho GTPase activity impairs lens fiber cell migration, elongation and survival.
    Maddala R; Reneker LW; Pendurthi B; Rao PV
    Dev Biol; 2008 Mar; 315(1):217-31. PubMed ID: 18234179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Rho family GTPases by Rho GDP dissociation inhibitor disrupts cardiac morphogenesis and inhibits cardiomyocyte proliferation.
    Wei L; Imanaka-Yoshida K; Wang L; Zhan S; Schneider MD; DeMayo FJ; Schwartz RJ
    Development; 2002 Apr; 129(7):1705-14. PubMed ID: 11923206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a novel protein with GDP dissociation inhibitor activity for the ras-like proteins CDC42Hs and rac I.
    Adra CN; Ko J; Leonard D; Wirth LJ; Cerione RA; Lim B
    Genes Chromosomes Cancer; 1993 Dec; 8(4):253-61. PubMed ID: 7512369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cloning and characterization of bovine low molecular weight GTPases (Rac1 and Rac2) and rho GDP-dissociation inhibitor 2 (D4-GDI).
    Davis AR; Clements MK; Bunger PL; Siemsen DW; Quinn MT
    Vet Immunol Immunopathol; 2000 May; 74(3-4):285-301. PubMed ID: 10802295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rho GTPase Cdc42 is essential for human T-cell development.
    Smits K; Iannucci V; Stove V; Van Hauwe P; Naessens E; Meuwissen PJ; Ariƫn KK; Bentahir M; Plum J; Verhasselt B
    Haematologica; 2010 Mar; 95(3):367-75. PubMed ID: 20207844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression and regulation of GTPases (RhoA and Rac2) and GDIs (LyGDI and RhoGDI) in neutrophils from patients with severe congenital neutropenia.
    Kasper B; Tidow N; Grothues D; Welte K
    Blood; 2000 May; 95(9):2947-53. PubMed ID: 10779444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.